http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-29824969-U1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_501803c7b2b9992fbc289a3a3c143ad3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f583df5462434b82cdc51dd870e9e9a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae6010cc7b8f482d2d567730e7c335b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce7d6fa8059c3c5efd363575c088def6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f92dffd444d03d7c87461461aa83ba84
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C06D7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C06D7-00
filingDate 1998-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2003-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-29824969-U1
titleOfInvention Tear gas containing perlagonic acid vanillylamide
abstract An incapacitant mixture comprises pelargonic acid vanillylamide (PAVA) and a solvent, and the mixture can induce temporary blindness in a human or animal. Also claimed is an incapacitant spray comprising a means for storing and delivering the above mixture. Preferably the mixture can induce temporary blindness for >5 minutes and it contains 1% or less (more preferably 0.01-0.65%) of PAVA. The solvent is ethanol, water, isopropanol, methyl chloride or methanol. The incapacitant may be PAVA or primarily PAVA with other incapacitants, e.g. CS, Oleoresin Capsicum (OC) or CN gas. The mixture may also contain a dye or marker. (1) PAVA (0.64%), 50:50 water:isopropanol and a propellent or (2) PAVA (0.01%), alcohol (preferably isopropanol) (3%), water (96.99%) and a propellant (preferably carbon dioxide). The delivery system uses an aerosol propellant or pressurised air to expel the mixture from the storage means, preferably a canister.
priorityDate 1997-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414305203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411583174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887

Total number of triples: 36.